Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By IPO Scoop (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

The IPO Buzz: Wealthfront (WLTH Proposed) Sets Terms for $450 Million IPO

% of readers think this story is Fact. Add your two cents.


Wealthfront Corp. (WLTH Proposed), an automated wealth management firm that focuses on “digital native” clients – namely, Millennials and Gen Z people, unveiled the terms for its $450 million IPO early today – Tuesday, Dec. 2, 2025. The deal consists of 34.62 million shares at a price range of $12.00 to $14.00 to raise $450.06 million, if priced at the $13.00 mid-point of its range, according to the S-1/A filing dated Dec. 2, 2025. Wealthfront would have a market cap of about $1.9 billion – assuming the IPO is priced at  the $13.00 mid-point of its range.

Wealthfront’s IPO is expected to price during the week of Dec. 8, 2025. This is a NASDAQ listing.

Goldman Sachs and J.P. Morgan are the lead joint book-runners of Wealthfront’s IPO. Citigroup, Wells Fargo Securities and RBC Capital Markets are also joint book-runners on the deal.

The Wealthfront IPO is the third large IPO to launch since early Monday morning (Dec. 1, 2025) and land on the IPO Calendar for pricing next week. It joins Cardinal Infrastructure (CRDL Proposed), a $242 million IPO led by Stifel and William Blair, and Lumexa Imaging Holdings, Inc. (LMRI Proposed), a $462.5 million IPO led by Barclays and J.P. Morgan, in the line-up for pricing next week.

Of the 34.62 million shares in Wealthfront’s IPO, Wealthfront is offering about 21.47 million shares while selling shareholders are offering about 13.15 million shares. Wealthfront will not receive any proceeds from the sale of the selling stockholders’ shares.

Wealthfront expects to receive net proceeds of about $255.2 million, if the IPO is priced at the $13.00 mid-point of its range, according to the prospectus. The company plans to use some of the IPO’s proceeds to repay $200 million of debt under a revolving credit facility, the prospectus said.

Wealthfront, based in Palo Alto, California, is an automated wealth management platform – also known as a “robo-advisor” – whose target clientele consists of people born after 1980. The average age of its “individual funded client is 38,” Wealthfront said in the prospectus. The company was founded in 2007. From the prospectus:

“We’re a different kind of FinTech. We are a technology company that built a financial solutions platform for “digital natives,” defined as those born after 1980 (i.e., Millennials, Gen Z, and later generations). Our platform is designed to address the needs of the wealth builders within these generations. We have differentiated, trusted relationships with our clients due to our unique and fundamentally aligned incentives. Simply put, we succeed because our clients succeed.

“We were among the first digital-only financial solutions platforms, and we pioneered using automation to offer low-cost diversified portfolios. We built our platform using software to deliver our solutions quickly, conveniently, and at low cost. These principles align with the preferences of digital natives, who use digital platforms for the vast majority of their everyday services ranging from entertainment and commerce to food delivery and ride sharing.

“Our technology-driven financial solutions help clients turn savings into long-term wealth. Our broad suite of products, including cash management, investment advisory, borrowing and lending, and financial planning solutions, address the diverse financial needs of our clients regardless of the economic environment.”

As of July 31, 2025, Wealthfront had over 1.3 million funded clients who earn about $165,000 a year, the prospectus said. On that date, Wealthfront had $88.2 billion in platform assets.

Wealthfront is profitable, according to the prospectus: Net income of $122.8 million on revenue of $338.6 million for the 12 months that ended July 31, 2025.


Source: https://www.iposcoop.com/the-ipo-buzz-wealthfront-wlth-proposed-sets-terms-for-450-million-ipo/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login